The results showed that as compared to the TMZ group, the proliferation ability of GBM cells treated with KPNB1 knockdown combined with TMZ was further inhibited, and the number of apoptotic cells was further increased (Supplementary Fig. S1K and S1L). The gene discussed is KPNB1; the disease is glioblastoma.